Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Z0CU
|
|||
| Former ID |
DIB000046
|
|||
| Drug Name |
Cx-621
|
|||
| Synonyms |
Allogeneic adipose-derived mesenchymal stem cells (intralymphatic, inflammatory/autoimmune disease), Cellerix; Allogeneic adipose-derived mesenchymal stem cells (intralymphatic, inflammatory/autoimmune disease), TiGenix
Click to Show/Hide
|
|||
| Indication | Autoimmune diabetes [ICD-11: 5A10] | Phase 1 | [1] | |
| Company |
Mesoblast; stemedica cell technologies
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800035385) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.